510(k) · Cleared

Cleared

Bec Needleless Injection Site

K961327510(k) TraditionalCleared May 15, 199637-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biological & Environmental Control Laboratories · FPA Set, Administration, Intravascular

Cleared on May 15, 1996 as substantially equivalent to K953343 (Medical Associates Network, Inc., 1995) and 1 other predicate after a 37-day review. Its family tree reaches back 1 generation to 1995.

Decided: May 15, 1996
Review: 37 days
Class: Class II
Product code: FPA
Recalls: None
Predicates: 2

Its longest line of descent runs back 1 generation to K944320 (1995). 2 ancestors in all. No later device cites it as a predicate yet.

By dateBy generation

Root · 1 generation backK944320 Vented/Non-Vented Gemini Administration SetImed Corp. · 1995 · Recalled
This deviceK961327 Bec Needleless Injection SiteBiological & Environmental Control Laboratories · 1996

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−1	K944320	Vented/Non-Vented Gemini Administration Set	Imed Corp.	1995	7
0 (this device)	K961327	Bec Needleless Injection Site	Biological & Environmental Control Laboratories	1996	—

Other ancestors by year cleared

Year cleared	Devices	With a Class I recall
1995	1	0

FIG. 1 — Lineage of K961327, 1995–1996Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

#1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
#2 Held for the reportin the report
#3 Held for the reportin the report

Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K953343	Needleless Injection Site Summary page 1 …use of a blunt cannula. This needleless injection site is iclentical to Medical Network Associates, Incorporated's Needleless Injection Site reviewed by FDA in 510(k) # K953343 which was identical to and found to be substantially equivalent to IMED Corporations Needleless Injection Site submitted under 51…	Medical Associates Network, Inc.	1995	—
*	K944320	Vented/Non-Vented Gemini Administration Set Summary page 1 …eviewed by FDA in 510(k) # K953343 which was identical to and found to be substantially equivalent to IMED Corporations Needleless Injection Site submitted under 510(k) #K944320. These injection sites are made of the same material by the same foreign manufacturer. Technological data and performance data we…	Imed Corp.	1995	7

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

1 of the 2 ancestors has a recall of any class.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FPA

11in 2025

2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	16	75	17	1,499
2008	18	89	15	1,941
2009	10	166	166	2,512
2010	23	120	58	2,537
2011	12	87	28	4,407
2012	21	96	16 (4)	4,930
2013	13	90	64	4,651
2014	22	89	24	4,695
2015	17	123	6	6,625
2016	12	195	10	8,470
2017	17	240	13	6,462
2018	4	177	4	6,574
2019	7	161	13	11,227
2020	10	327	107	9,563
2021	13	186	1	10,414
2022	14	213	9 (5)	13,393
2023	14	340	12 (4)	10,916
2024	7	244	13 (1)	47,210
2025	11	225	98 (1)	34,506
2026	5	266	10 (2)	—

What is it indicated for?

The Needleless injection Site is intended to provide additional protection against inadvertent "needlestick” injuries to health care providers during the administration of fluids and rmedications. The Needleless Injection Site provides for the entry to an intravascular administration set or catheter without the need of a sharp needie by allowing for the use of a blunt cannula.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

https://510kreport.com/device/K961327 · printed Nov 4, 2026

Cite this page

510(k) Report. “K961327: Bec Needleless Injection Site.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K961327

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026